Key result
Multi-omic profiling of myocardial hypertrophy shows potential to guide targeted therapies and personalized cardiovascular diagnostics.
Answers are grounded in this paper and cite their sources.
This review presents major directions in studies of myocardial hypertrophy from the aspect of transcriptomics and metabolomics. Understanding of trigger mechanisms of myocardial hypertrophy will permit transition from basic studies to individualized clinical application of innovative technologies in the treatment of heart diseases, such as targeted therapy. At the present time, methods have been developed for diagnostics and prediction of cardiovascular diseases based on the metabolomic profiling and the evaluation of microRNA expression. Progress in studying molecular and genetic processes underlying the development of cardiovascular diseases may provide invaluable information for clinical cardiology.
No takes yet. Share an insight, caveat, or question.
Shakaryants et al. (2020) conducted a review in Myocardial hypertrophy. Transcriptomic and metabolomic profiling of myocardial hypertrophy may enable individualized clinical applications such as targeted therapy and improved cardiovascular diagnostics.
Synapse has enriched 10 related papers. Consider them for comparative context: